A prespecified analysis of this trial showed that a greater weight loss was associated with greater improvements in HF-related symptoms and physical limitations, regardless of patients age, gender and baseline body weight 89
Although research on these new targets has not yet entered the phase of clinical trials, they will most likely become the mainstay of treatment for UC in the future (Table 3)
Romano Danesi, University of Pisa, Italy Updates Copyright 2022 Mascolo, Di Napoli, Balzano, Cappetta, Urbanek, De Angelis, Scisciola, Di Meo, Sullo, Rafaniello and Sportiello
Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy
doi:10.1155/2020/5150684 Anana_go
A balanced diet rich in vitamins and minerals also supports muscle health